^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GBM6-AD

    i
    Other names: GBM6-AD, GBM6-AD lysate protein vaccine
    Associations

    News

    Trials
    Company:
    University of Minnesota
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    8ms
    CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults (clinicaltrials.gov)
    P1, N=24, Recruiting, OX2 Therapeutics
    New P1 trial
    |
    Zyclara (imiquimod) • CD200AR-L • GBM6-AD
    1year
    Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (clinicaltrials.gov)
    P1, N=28, Active, not recruiting, Jennie Taylor | Trial completion date: Aug 2023 --> Aug 2024
    Trial completion date
    |
    CD8 (cluster of differentiation 8) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CD4 (CD4 Molecule)
    |
    CXCL10 expression
    |
    GBM6-AD • Hiltonol (poly-ICLC)
    2years
    Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma (clinicaltrials.gov)
    P1, N=28, Active, not recruiting, Jennie Taylor | Trial primary completion date: Feb 2023 --> Aug 2022
    Trial primary completion date
    |
    CD8 (cluster of differentiation 8) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CD4 (CD4 Molecule)
    |
    GBM6-AD • Hiltonol (poly-ICLC)